文献速递腹部泌尿生殖CT

CT放射组学可能预测胰腺神经内分泌肿瘤的分级:一项多中心研究

CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
PubMed 文献 · Eur Radiol · 2019-06-21

本研究纳入两家机构经病理确诊的138例胰腺神经内分泌肿瘤(PNET)患者(训练队列104例,验证队列34例),从动脉期和门静脉期CT图像提取放射组学特征并构建融合放射组学标签,结合临床危险因素肿瘤边缘建立列线图,用于术前预测1级与2/3级肿瘤。列线图在训练队列AUC为0.974(95%CI 0.950-0.998),验证队列AUC为0.902(95%CI 0.798-1.000),校准良好,决策曲线分析验证了临床实用性。

要点

  • 融合放射组学标签与组织学分级显著相关(p<0.001)。
  • 列线图整合肿瘤边缘与融合放射组学标签,训练队列AUC 0.974、验证队列AUC 0.902。
  • 动脉期与门静脉期CT对PNET分级预测具有互补性。

核心结论

  • 由肿瘤边缘和融合放射组学标签组成的综合列线图可作为术前预测1级与2/3级PNET的有力工具,并辅助PNET患者的临床决策。
  • 放射组学标签对PNET的组织学分级具有强判别能力。

研究设计与样本

  • 回顾性研究,纳入两家机构经病理确诊的PNET患者138例,训练队列104例,验证队列34例。
  • 从动脉期和门静脉期CT图像分别提取853个放射组学特征,采用最小冗余最大相关和随机森林方法筛选特征并构建放射组学标签,融合两期单相标签生成融合放射组学标签。
  • 基于整合临床危险因素和融合放射组学标签的综合模型建立列线图,并应用决策曲线分析评估临床用途。

诊断标准与关键数值

  • 融合放射组学标签与组织学分级显著相关(p<0.001)。
  • 列线图整合独立临床危险因素肿瘤边缘和融合放射组学标签,训练队列AUC为0.974(95%CI 0.950-0.998),验证队列AUC为0.902(95%CI 0.798-1.000),校准良好。
  • 决策曲线分析验证了预测列线图的临床实用性。
  • 列线图在辅助PNET患者治疗策略方面优于临床因素。

临床应用与阅片要点

  • 作者提出综合列线图可作为术前预测1级与2/3级PNET并辅助临床决策的工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a radiomics-based nomogram for preoperatively predicting grade 1 and grade 2/3 tumors in patients with pancreatic neuroendocrine tumors (PNETs).

METHODS: One hundred thirty-eight patients derived from two institutions with pathologically confirmed PNETs (104 in the training cohort and 34 in the validation cohort) were included in this retrospective study. A total of 853 radiomic features were extracted from arterial and portal venous phase CT images respectively. Minimum redundancy maximum relevance and random forest methods were adopted for the significant radiomic feature selection and radiomic signature construction. A fusion radiomic signature was generated by combining both the single-phase signatures. The nomogram based on a comprehensive model incorporating the clinical risk factors and the fusion radiomic signature was established, and decision curve analysis was applied for clinical use.

RESULTS: The fusion radiomic signature has significant association with histologic grade (p < 0.001). The nomogram integrating independent clinical risk factor tumor margin and fusion radiomic signature showed strong discrimination with an area under the curve (AUC) of 0.974 (95% CI 0.950-0.998) in the training cohort and 0.902 (95% CI 0.798-1.000) in the validation cohort with good calibration. Decision curve analysis verified the clinical usefulness of the predictive nomogram.

CONCLUSION: We proposed a comprehensive nomogram consisting of tumor margin and fusion radiomic signature as a powerful tool to predict grade 1 and grade 2/3 PNET preoperatively and assist the clinical decision-making for PNET patients.

KEY POINTS: • Radiomic signature has strong discriminatory ability for the histologic grade of PNETs. • Arterial and portal venous phase CT imaging are complementary for the prediction of PNET grading. • The comprehensive nomogram outperformed clinical factors in assisting therapy strategy in PNET patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Gu D, Hu Y, Ding H, et al. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol. 2019. PMID: 31227882. doi:10.1007/s00330-019-06176-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。